Carlyle Q4 GAAP EPS $0.35, FY22 EPS $3.35; raises quarterly dividend to $0.35

Carlyle Group Inc.

2022-FY EPS reported $3.35 revenue$4,438,700,000

Q4 2022 net income to common shareholders $127M ($0.35 diluted EPS); full-year net income $1.2B ($3.35 diluted EPS).
Board declared Q1 dividend of $0.325/share (payable March 1) and approved increase to $0.35/quarter ($1.40 annual) starting Q2.
Management highlights Harvey Schwartz as new CEO; Conway remains Co-founder and interim CEO.
Total balance sheet assets $21B as of Dec 31, 2022; income before taxes $172M in Q4 and $1.6B for full year.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Carlyle Group Inc. reported Q4 2022 and full year 2022 results: net income net income attributable to The Carlyle Group Inc. common shareholders of $127 million and $1.2 billion, EPS net income per common share of $0.35 and $3.35, on a diluted basis.

Period: Q4 2022 and full year 2022
Net income: net income attributable to The Carlyle Group Inc. common shareholders of $127 million and $1.2 billion
EPS: net income per common share of $0.35 and $3.35, on a diluted basis
Result: reported results

Exact text from the filing

U.S. GAAP results for Q4 2022 and 2022 included income before provision for income taxes of $172 million and $1.6 billion, and net income attributable to The Carlyle Group Inc. common shareholders of $127 million and $1.2 billion, or net income per common share of $0.35 and $3.35, on a diluted basis.

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Carlyle Group Inc. filing history →

Source: SEC EDGAR

accession 0001527166-23-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.